References
- Mead M. G., Dangerfield W. G. The investigation of ‘Midband’ lipoproteins using polyacrylamide gel electrophoresis. Clin Chim Acta. 1974; 51: 173–82
- Gaubatz J. W., Chari M. V., Nava M. L., Guyton J. R., Morrisett J. D. Isolation and characterization of the two major apoproteins in human lipoprotein-[a]. J Lipid Res. 1987; 28: 69–79
- Guyton J. R., Dahlen G. H., Patsch W., Kauts J. A., Gotto A. M. Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis. 1985; 5: 265–72
- Rhoads G. G., Dahlen G., Berg K., Morton N. E., Dannenberg A. L. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 1986; 256: 2540–4
- Kameda K., Matsuzawa Y., Kubo M., Ishikawa K., Maejima I., Yamamura T., Yamamoto A., Tarui S. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan. Atherosclerosis. 1984; 51: 241–9
- Stone N. J., Levy R. I., Fredrickson D. S., Verter J. Coronary artery disease in 116 kindreds with familial type II hypercholesterolemia. Circulation. 1974; 49: 476–88
- Nikkila E. A., Aro A. Family study of serum lipids and lipoproteins in coronary heart disease. Lancet. 1973; i: 954–9
- Goldstein J. L., Brown M. S. Familial hypercholesterolemia. The metabolic basis of inherited disease, 6th edn., C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle. McGraw-Hill, New York 1989; 1215–50
- Heiberg A., Slack J. Family similarities in the age at coronary death in familial hypercholesterolemia. Br Med J. 1977; ii: 493–5
- Thojnpson G. R., Seed M., Niththyananthan S., McCarthy S., Thorogood M. Genotypic and phenotypic variation in familial hypercholesterolemia. Arteriosclerosis. 1989; 9: 1–75
- Miettinen T. A., Glylling H. Mortality and cholesterol metabolism in familial hypercholesterolemia. Arteriosclerosis. 1988; 8: 163–7
- Wiklund O., Angelin B., Olofsson S. O., Eriksson M., Fager G., Berglund L., Bondjers G. Apolipo-protein(a) and ischemic heart disease in familial hypercholesterolemia. Lancet. 1990; 335: 1360–63
- Richmond W. Preparation and properties of cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem. 1973; 19: 1350–6
- Smith L., Lucas D., Lehmnus G. Automated measurement of total cholesterol and triglycerides, in “Tandem”, on the discrete sample analyzer, Gilford system 3500. Clin Chem. 1979; 25: 439–42
- Narayan K. A., Narayan S., Kummerou F. A. Disk electrophoresis of human serum lipoproteins. Nature 1965; 205: 246–8
- Judkins M. P. Selective coronary arteriography. A percutaneous transfemoral technic. Radiology 1967; 89: 815–24
- AHA Committee Report. A reporting system on patients, evaluated for coronary disease. Circulation 1975; 51: 7
- Kawano M., Shinomiya M., Tashiro J., Shirai K., Saito Y., Yoshida S. Significance of compositions of “midband” in diabetes mellitus. Complication of Diabetes Mellitus 1989; 2: 129–35
- Seed M., Hoppichiler F., Reaveley D., McCarthy S., Thompson G. R., Boerwinkle E., Utermann G. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in familial hypercholesterolemia. New Eng J Med. 1990; 332: 1494–9